Evaluation of Electronic Pregnancy Registers and Mobile Applications for Monitoring Pregnancy Outcomes ( EVAPREAP )
1 other identifier
observational
2,000
4 countries
4
Brief Summary
Monitoring pregnancy outcomes during pregnancy is very important in assessing the effectiveness of interventions. This study aims to create pregnancy registers and evaluate pregnancy mobile applications as a potential tool for monitoring pregnancy outcomes in future placental malaria (PM) vaccine trials, as well as for the implementation of any other intervention in this target group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2023
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2023
CompletedFirst Submitted
Initial submission to the registry
January 17, 2024
CompletedFirst Posted
Study publicly available on registry
January 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2025
CompletedAugust 5, 2025
August 1, 2025
1.6 years
January 17, 2024
August 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Feasibility of mobile application for registration of pregnant women and tracking pregnancy outcomes
Assess whether an open-source mobile applications is easy and convenient to use accounting for advantages and disadvantages to guide integrating the App into routine workflow via qualitative methods: In-depth interviews (IDIs) and focus group discussions (FGDs)
9 months
Usability of mobile application for registration of pregnant women and tracking pregnancy outcomes
Assess whether open-source mobile applications could be used by pregnant women and health workers to adequately record, track, and summarize data, including whether it functioned in a way that enhanced productivity or led to unproductive tasks due to errors. The assessment will be done using qualitative methods: In-depth interviews (IDIs) and focus group discussions (FGDs)
9 months
Acceptability of mobile application for registration of pregnant women and tracking pregnancy outcomes
Acceptability will be defined as pregnant women and health workers and other stakeholders found the Client Data App acceptability, including its interface and navigation features. The assessment will be done using qualitative methods: In-depth interviews (IDIs) and focus group discussions (FGDs)
9 months
Study Arms (2)
Pregnant women
Health care providers
In-depth interviews (IDIs) and focus group discussions (FGDs) will be used to assess the user experience and the perceptions of pregnant women and health workers on the feasibility, usability, and acceptability of open-source mobile applications for tracking pregnancy outcomes
Interventions
Electronic pregnancy register will be created based on local ANC register to monitor pregnancy outcomes across all sites. Pregnant women of all ages attending antenatal care (ANC) facility will be registered
In-depth interviews (IDIs) and focus group discussions (FGDs) will be used to assess the user experience and the perceptions of pregnant women and health workers on the feasibility, usability, and acceptability of open-source mobile applications for tracking pregnancy outcomes
Eligibility Criteria
Phase 1 study population will include pregnant women of all ages attending antenatal care (ANC) facility. Phase 2 study population will include pregnant women aged 15-49 years attending ANC facility and health workers who provide healthcare services to pregnant women at ANC clinics or Maternity ward
You may qualify if:
- Pregnant women attending ANC facility in the study area
- Pregnant women whose ANC information can be accessed at the ANC facility
- Health workers providing care to pregnant women at ANC or Maternity facilities
You may not qualify if:
- Pregnant women attending ANC outside the study area
- Pregnant women whose ANC information cannot be accessed at the ANC facility
- Pregnant women unwilling or unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- European Vaccine Initiativelead
- Kintampo Health Research Centre, Ghanacollaborator
- Fondation pour la Recherche Scientifique, Benincollaborator
- Groupe de Recherche Action en Santecollaborator
- Malawi University of Science and Technologycollaborator
Study Sites (4)
Fondation pour la Recherche Scientifique (FORS)
Cotonou, Benin
Groupe de Recherche Action en Santé (GRAS)
Ouagadougou, Burkina Faso
Kintampo Health Research Centre (KHRC)
Kintampo, Ghana
Malawi University of Science and Technology (MUST)
Mikolongwe, Malawi
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Kwaku Poku Asante, MD, PhD
Kintampo Health Research Centre, Ghana
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 9 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2024
First Posted
January 26, 2024
Study Start
October 1, 2023
Primary Completion
April 30, 2025
Study Completion
April 30, 2025
Last Updated
August 5, 2025
Record last verified: 2025-08